Subscribe to RSS
DOI: 10.1055/s-2008-1032043
RCM-Mediated Synthesis of Fluorinated Cyclic Hydrazines
Publication History
Publication Date:
16 January 2008 (online)
![](https://www.thieme-connect.de/media/synlett/200803/lookinside/thumbnails/10.1055-s-2008-1032043-1.jpg)
Abstract
A series of fluorinated cyclic hydrazine derivatives has been prepared in a straightforward manner using ring-closing metathesis (RCM) of fluorinated- and trifluoromethylated olefins as the key step.
Key words
cyclic hydrazines - ring-closing metathesis - fluorinated heterocycles - trifluoromethylated heterocycles
- 1
Indelicato JM.Pasini CE. J. Med. Chem. 1988, 31: 1227 - 2 For an entry into sanglifehrin synthesis, see e.g.:
Lindel T. Sanglifehrin A: An Immunosuppressant Natural Product, In Organic Synthesis Highlights V Vol. 5:Schmalz HG.Wirth T. Wiley-VCH; Weinheim: 2003. p.350 - 3
Ahn JH.Shin MS.Jun MA.Jung SH.Kang SK.Kim KR.Rhee SD.Kang NS.Kim SY.Sohn S.-K.Kim SG.Jin MS.Lee JO.Cheon HG.Kim SS.Soo S. Bioorg. Med. Chem. Lett. 2007, 17: 2622 - For reviews, see:
-
4a
Ciufolini MA.Xi N. Chem. Soc. Rev. 1998, 27: 437 -
4b
Müller E. In Houben-Weyl 4th ed., Vol. 10/2:Müller E. Thieme; Stuttgart: 1971. p.123 -
4c
Jensen-Korte U.Müller N.Schallner O. In Houben-Weyl 4th ed., Vol. E16a/1:Klamman D. Thieme; Stuttgart: 1990. p.412 -
5a
Tae J.Hahn D.-W. Tetrahedron Lett. 2004, 45: 3757 -
5b
Kim YJ.Lee D. Org. Lett. 2004, 6: 4351 -
6a
Fustero S.Sanz-Cervera JF.Piera J.Sanchez-Rosello M.Chiva G.Simon-Fuentes A. J. Fluorine Chem. 2004, 125: 621 -
6b
Chanteau F.Didier B.Dondy B.Doussot P.Plantier-Royon R.Portella C. Eur. J. Org. Chem. 2004, 1444 -
6c
Tews S.Miethchen R.Reinke H. Synthesis 2003, 707 -
6d
Gille S.Ferry A.Billard T.Langlois BR. J. Org. Chem. 2003, 68: 8932 -
6e
Kobayashi Y.Taguchi T. J. Fluorine Chem. 2000, 105: 197 - For reviews, see, for example:
-
6f
Leroux F.Jeschke P.Schlosser M. Chem. Rev. 2005, 105: 827 -
6g
Shimizu M.Hiyama T. Angew. Chem. Int. Ed. 2005, 44: 214 -
6h
Dolbier WR.Battiste MA. Chem. Rev. 2003, 103: 1071 -
7a
Rutjes FPJT.Paz H.Hiemstra MM.Speckamp WN. Tetrahedron Lett. 1991, 32: 6629 -
7b
Rutjes FPJT.Hiemstra H.Mooiweer HH.Speckamp WN. Tetrahedron Lett. 1988, 29: 6975 -
7c
Rutjes FPJT.Teerhuis NM.Hiemstra H.Speckamp WN. Tetrahedron 1993, 49: 8605 -
7d
Rutjes FPJT.Hiemstra H.Pirrung FOH.Speckamp WN. Tetrahedron 1993, 49: 10027 -
8a
Rutjes FPJT.Schoemaker HE. Tetrahedron Lett. 1997, 38: 677 -
8b
Tjen KCMF.Kinderman SS.Schoemaker HE.Hiemstra H.Rutjes FPJT. Chem. Commun. 2000, 699 -
8c
Kinderman SS.van Maarseveen JH.Schoemaker HE.Hiemstra H.Rutjes FPJT. Org. Lett. 2001, 3: 2045 -
8d
Kinderman SS.de Gelder R.van Maarseveen JH.Schoemaker HE.Hiemstra H.Rutjes FPJT. J. Am. Chem. Soc. 2004, 126: 4100 -
8e
Kinderman SS.Wekking MMT.van Maarseveen JH.Schoemaker HE.Hiemstra H.Rutjes FPJT. J. Org. Chem. 2005, 70: 5519 -
8f
Wijdeven MA.Botman PNM.Wijtmans R.Schoemaker HE.Rutjes FPJT.Blaauw RH. Org. Lett. 2005, 7: 4005 - 9 For an excellent review on RCM-mediated synthesis of aza- and oxacycles, see e.g.:
Deiters A.Martin SF. Chem. Rev. 2004, 104: 2199 -
10a
De Matteis V.van Delft FL.Tiebes J.Rutjes FPJT. Eur. J. Org. Chem. 2006, 1166 -
10b
De Matteis V.Dufay O.Waalboer DCJ.van Delft FL.Tiebes J.Rutjes FPJT. Eur. J. Org. Chem. 2007, 2667 -
11a
De Matteis V.van Delft FL.De Gelder R.Tiebes J.Rutjes FPJT. Tetrahedron Lett. 2004, 45: 959 -
11b
De Matteis V.van Delft FL.Jakobi H.Lindell S.Tiebes J.Rutjes FPJT. J. Org. Chem. 2006, 71: 7527 -
12a
Salim SS.Bellingham RK.Satcharoen V.Brown R. Org. Lett. 2003, 5: 3403 -
12b
Marhold M.Buer A.Hiemstra H.van Maarseveen JH.Haufe G. Tetrahedron Lett. 2004, 45: 57 - For other examples of Ru-mediated isomerization, see e.g.:
-
13a
Kinderman SS.van Maarseveen JH.Schoemaker HE.Hiemstra H.Rutjes FPJT. Org. Lett. 2001, 3: 2045 -
13b
Schmidt B. Eur. J. Org. Chem. 2004, 1865 -
13c
Schmidt B. J. Mol. Catal. A: Chem. 2006, 254: 53 -
13d
Alcaide B.Almendros P.Alonso JM. Chem. Eur. J. 2006, 12: 2874 ; and references cited therein -
13e
Hekking KFW.Moelands MAH.van Delft FL.Rutjes FPJT. J. Org. Chem. 2006, 71: 6444
References and Notes
Representative Procedures N ′-(1-Phenylbut-3-enyl)hydrazinecarboxylic Acid tert -Butyl Ester (31)Allylmagnesium bromide (4.57 mL of a 1.0 M solution in Et2O, 4.57 mmol) was added at -78 °C to a well-stirred solution of 13 (336 mg, 1.53 mmol) in THF (2 mL). The mixture was stirred at -78 °C for 1 h and allowed over 12 h to reach r.t. It was poured into aq sat. NH4Cl and the aqueous layer was extracted with Et2O (3 × 6 mL). The ether layers were dried (MgSO4), evaporated, and the crude product 31 (135 mg, 40%) was obtained as a colorless oil. IR (neat): 3403, 3283, 3067, 3028, 2980, 2928, 1709, 1455, 1368, 1282, 1243, 1156, 1022, 919, 759, 698 cm-1. 1H NMR (300 MHz, CDCl3, 25 °C, TMS): δ = 7.31-7.24 (m, 5 H, Ph), 6.22, (s, 1 H, BocNH), 5.83-5.69 (m, 1 H, CH=CH2), 5.13-5.03 (m, 2 H, CH=CH 2), 4.32 (br s, 1 H, PhCH), 4.11 (br s, 1 H, BocNHNH), 2.42-2.37 (m, 2 H, PhCHCH 2), 1.41 (s, 9 H, 3 CH 3). 13C NMR (75 MHz, CDCl3, 25 °C): δ = 156.6, 141.9, 134.7, 128.4, 127.8, 127.5, 117.9, 80.3, 63.3, 40.3, 28.4. ESI-HRMS: m/z calcd for C15H22N2O2Na [M+ + Na]: 285.1579; found: 285.15766.N ′-Phenylacetyl- N ′-(1-phenylbut-3-enyl)hydrazine-carboxylic Acid tert -Butyl Ester (32)To a solution of phenylacetylchloride (64.8 µL, 0.5 mmol) in THF (2 mL), Et3N (69.7 l, 0.5 mmol) was added at 0 °C and the mixture was stirred at 0 °C for 30 min. At the same temperature compound 31 (130 mg, 0.51 mmol) was added and the mixture was allowed to reach r.t. over 12 h. The solvent was evaporated and the residue was purified using column chromatography (heptane-EtOAc, 10:1 to 6:1) to give 32 (166 mg, 89%) as a white solid; mp 107-109 °C. IR (neat): 3278, 3028, 2980, 2933, 1705, 1658, 1493, 1455, 1394, 1368, 1251, 1156, 707, 607 cm-1. 1H NMR (300 MHz, CDCl3, 25 °C, TMS, some signals appear as rotamers): δ = 7.40-7.14 (m, 10 H, Ar), 6.10 (br s, 1 H, NH), 5.88-5.52 (m, 2 H, CHPh, CH2=CH), 5.14-5.85 (m, 2 H, H 2C=CH), 3.72-3.63 (m, 2 H, CH2Ph), 2.73-2.50 (m, 2 H, PhCHCH 2), 1.50 and 1.30 (s, 9 H, 3 CH3). 13C NMR (75 MHz, CDCl3, 25 °C): δ = 165.2, 150.6, 145.2, 134.7, 130.8, 129.3, 129.1, 128.0, 127.8, 127.3, 126.9, 117.4, 81.9, 58.8, 49.2, 40.6, 28.4. HRMS (CI): m/z calcd for C23H29N2O3 [M+ + H]: 381.2178; found: 381.2188.N -(2-Fluoroallyl)- N ′-phenylacetyl- N ′-(1-phenylbut-3-enyl)hydrazinecarboxylic Acid tert -Butyl Ester (33)To a suspension of NaH (14 mg, 0.57 mmol) in DMF (5 mL) was added at 0 °C compound 32 (166 mg, 0.44 mmol). After stirring for 15 min at r.t., 1-chloro-2-fluoroprop-2-ene (18, 42 mg, 0.44 mmol) was added slowly. The reaction was stirred for 12 h, quenched with H2O (5 mL) and extracted with Et2O (3 × 5 mL). The ether layers were dried (MgSO4), evaporated, and the residue was purified using column chromatography (heptane-EtOAc, 10:1) to give 33 (104 mg, 54%) as a colorless oil. IR (neat): 3062, 3032, 2976, 2928, 1718, 1679, 1497, 1450, 1364, 1251, 1156, 1031, 914, 854, 763, 698 cm-1. 1H NMR (300 MHz, CDCl3, 25 °C, TMS, some signals appear as rotamers): δ = 7.41-7.25 (m, 10 H, Ar), 5.65-5.43 (m, 3 H, CH 2=CH, CH2=CH), 5.07-4.35 (m, 6 H, CH 2=CH, FC=CH 2, CHPh, NCH2), 4.00-3.91 (m, 1 H, NCH2), 3.72-3.54 (m, 2 H, CH2Ph), 2.92 (br s, 2 H, PhCHCH 2), 1.42 and 1.22 (s, 9 H, 3 CH3). 13C NMR (75 MHz, CDCl3, 25 °C, some signals appear as rotamers): δ = 173.8, 160.3 (d, J = 260.1 Hz, CF), 169.0, 134.3, 134.2, 133.8, 129.2, 129.1, 128.2, 127.8, 127.2, 126.3, 122.9, 95.5-95.2 (m, CH2=CF), 82.2, 62.8, 39.8, 38.5, 37.5 (d, J = 48.8 Hz, CH2CF), 27.8 and 27.3, HRMS (CI): m/z calcd for C26H32N2O3F [M+ + H]: 439.2397; found: 439.2389.6-Fluoro-3-phenyl-2-phenylacetyl-2,3,4,7-tetrahydro[1,2]diazepine-1-carboxylic Acid tert -Butyl Ester (34)To a solution of compound 33 (90 mg, 0.2 mmol) in anhyd toluene (40 mL) Grubbs II catalyst (20 mol%) was added at 100 °C in small portions over 2 h. The mixture was then evaporated and the product was purified using column chromatography (heptane-EtOAc, 10:1) to give 34 (52 mg, 64%) as a white solid; mp 110-113 °C. IR (neat): 3058, 3028, 2967, 2898, 2859, 1722, 1689, 1493, 1450, 1368, 1260, 1230, 1161, 1117, 1096, 1027, 858, 806, 698, 659, 517 cm-1. 1H NMR (300 MHz, CDCl3, 25 °C, TMS, some signals appear as rotamers): δ = 7.37-7.08 (m, 10 H, Ar), 5.48 and 5.30 (br s, 1 H, CHPh), 5.30-4.86 (m, 1 H, CF=CH), 4.74 and 4.41 (d, J = 18.3, 1 H, NCH2), 3.74-3.61 (m, 2 H, CH2Ph), 3.22-3.12 (m, 1 H, NCH2), 2.74-2.65 (m, 1 H, CH 2CHPh), 2.19-2.10 (m, 1 H, CH 2CHPh), 1.56 and 1.51 (s, 9 H, 3 CH3). 13C NMR (75 MHz, CDCl3, 25 °C, some signals appear as rotamers): δ = 173.7 and 173.4, 156.3 and 155.9 (d, J = 254.7 Hz, CF), 155.5 and 154.6, 141.5 and 141.3, 134.9 and 134.4, 129.2, 128.8, 128.7, 128.4, 127.3, 127.1, 126.9, 125.7, 101.2 and 100.6 (d, J = 18.9 Hz, C=CF), 83.5, 65.3 and 64.8, 50.2 and 48.6 (d, J = 42.8 Hz, NCH2), 42.2 and 41.9, 28.3. HRMS (CI): m/z calcd for C24H28FN2O3 [M+ + H]: 411.2084; found: 411.2075.
15Crystallographic data have been deposited at the Cambridge Crystallographic Data Centre as supplementary publication no. CCDC 666813.